FindTrial
Sign In

Inactivated trivalent influenza vaccine

BIOLOGICAL7 trials

Sponsors

Seqirus, Wayne Sullender, M.D., Neufeld, Ellis J, MD, PhD, McMaster University, Advagene Biopharma Co. Ltd.

Conditions

Heart FailureIdiopathic Thrombocytopenic PurpuraImmune Thrombocytopenic PurpuraInfluenzaInfluenza InfectionInfluenza VaccineNon Small Cell Lung Cancer

Phase 2

A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants
CompletedNCT00479648
SeqirusInfluenza
Start: 2007-05-31End: 2007-08-31Updated: 2016-07-19
A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult
CompletedNCT03784885
Advagene Biopharma Co. Ltd.Influenza Infection
Start: 2017-09-01End: 2018-10-30Updated: 2018-12-26

Phase 4

Direct and Indirect Protection by Influenza Vaccine Given to Children in India
CompletedNCT00934245
Wayne Sullender, M.D.Influenza
Start: 2009-09-30End: 2012-07-31Updated: 2013-02-22
Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
CompletedNCT01945268
McMaster UniversityHeart Failure
Start: 2015-04-30End: 2015-12-31Updated: 2018-10-26
Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
NCT02762851
McMaster UniversityHeart Failure, Influenza
Start: 2016-06-30End: 2020-12-31Target: 5000Updated: 2018-10-26

Unknown Phase

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
CompletedNCT01713855
Neufeld, Ellis J, MD, PhDIdiopathic Thrombocytopenic Purpura, Immune Thrombocytopenic Purpura
Start: 2004-10-31End: 2006-03-31Updated: 2012-10-25
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
NCT04355806
Shanghai Pulmonary Hospital, Shanghai, ChinaInfluenza Vaccine, Non Small Cell Lung Cancer
Start: 2020-06-01End: 2023-05-31Target: 160Updated: 2020-04-21

Related Papers

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
2022-12-0153 citations
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study.
2019-12-0413 citations
Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.
2019-07-0119 citations
Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design
American Heart Journal2019-03-1146 citations